Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 28, 2025
Reporting Period: Single event date (February 28, 2025)
This filing serves as a Regulation FD disclosure regarding upcoming investor presentations by the Company's leadership. It does not contain periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on corporate events rather than financial performance.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces scheduled conference appearances.
Guidance, Outlook, and Management Commentary
Upcoming Events:
- TD Cowen 45th Annual Healthcare Conference: Fireside chat with Jasbir Seehra, Chair and CEO, on Monday, March 3, 2025, at 9:50 a.m. Eastern time.
- Leerink Partners Global Healthcare Conference: Fireside chat with Jasbir Seehra, Chair and CEO, on Monday, March 10, 2025, at 1:40 p.m. Eastern time.
Legal Disclaimer: The information in this report and the accompanying press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific dates and times for the TD Cowen and Leerink Partners conference calls.
- Review the full text of the press release (Exhibit 99.1) for any additional details on the presentation topics.
- Confirm that no financial guidance was issued in this specific 8-K filing; investors should refer to the most recent 10-K or 10-Q for financial data.